Esophagus - Cancer

JANS Article

Chyle Leak Following Radical En Bloc Esophagectomy with Two-Field Nodal Dissection: Predisposing Factors, Management, and Outcomes

June 10, 2021 | Mark FergusonBronze Contributor

Chyle leak remains a challenging postoperative complication to manage, and avoidance is always easier than mitigation. The only predisposing factor identified in this study was low BMI. Although ICU stay was longer in affected patients,...

JANS Article

Thoracic Surgical Oncology Group: An American Association for Thoracic Surgery Clinical Trials Initiative

June 13, 2024 | Mujtaba MubashirGold Contributor

This editorial summarizes the landscape that led to the founding of the Thoracic Surgical Oncology Group in 2017, in an era when, due to various oncology group reorganizations, a need...

JANS Article

Recovery of Patient-Reported Quality of Life After Esophagectomy

April 13, 2023 | Cameron LindSilver Contributor

This study aimed to measure the quality of life (QOL) as reported by patients after esophagectomy, a procedure which has a high rate of mortality. Researchers found that the one...

JANS Article

Long-Term Quality of Life After Esophagectomy for Esophageal Cancer

February 9, 2023 | Cameron LindSilver Contributor

To understand the shift toward nonsurgical management of esophageal cancer, researchers set out to determine the long-term quality of life (QOL) after esophagectomy. This study found that, in esophagectomy patients...

JANS Article

Global Thoracic Surgery

August 27, 2022 | Emily FarkasBronze Contributor

The delivery of thoracic surgical care in less-resourced areas is explored in this landmark series of articles, hoping to engage the thoracic surgeon in global health equity. There is a...

JANS Article

What Should Be the Gold Standard for the Surgical Component in the Treatment of Locally Advanced Esophageal Cancer: Transthoracic Versus Transhiatal Esophagectomy

November 16, 2014 | Mark FergusonBronze Contributor

This retrospective study evaluated results of transthoracic (TTE) vs transhiatal (THE) esophagectomy in patients with squamous cell cancer and adenocarcinoma from two high volume centers. Prospensity score matching was used....

JANS Article

Author Financial Conflicts of Interest, Industry Funding, and Clinical Practice Guidelines for Anticancer Drugs

November 11, 2014 | Mark FergusonBronze Contributor

This study explored financial conflicts of interest (FCOI) among authors of published guidelines and consensus statements and their relationship to endorsement of specific drugs. 93% of recent articles reported FCOI...

JANS Article

Impact of Neoadjuvant Chemoradiotherapy on Postoperative Outcomes After Esophageal Cancer Resection: Results of a European Multicenter Study

October 8, 2014 | Mark FergusonBronze Contributor

This multicenter prospective trial evaluated the impact of induction therapy on anastomotic leak (AL) and other complications after esophagectomy. Of 2944 included pts, 593 had induction chemoradiotherapy. AL occurred in...

JANS Article

Prognostic Classification of Histopathologic Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma

October 8, 2014 | Mark FergusonBronze Contributor

The histologic response to induction therapy is usually a binary function. In the current study, the authors explored methods of refining the histologic response classification to improve prediction of prognosis...

JANS Article

Lymph Node Retrieval During Esophagectomy With and Without Neoadjuvant Chemoradiotherapy: Prognostic and Therapeutic Impact on Survival

October 8, 2014 | Mark FergusonBronze Contributor

It has recently been reported that the number of lymph nodes resected during esophagectomy is related to long-term survival, leading to recommendations for the proper extent of nodal dissection. The...

JANS Article

Prolonged Time to Surgery After Neoadjuvant Chemoradiotherapy Increases Histopathological Response Without Affecting Survival in Patients With Esophageal or Junctional Cancer

October 8, 2014 | Mark FergusonBronze Contributor

It has recently been reported that a longer interval to esophagectomy following induction therapy results in higher pathologic response rates. The current study used data from the CROSS trial to...

JANS Article

The Comprehensive Complication Index: A Novel and More Sensitive Endpoint for Assessing Outcome and Reducing Sample Size in Randomized Controlled Trials

October 8, 2014 | Mark FergusonBronze Contributor

The Comprehensive Complication Index (CCI) was compared to more standard methods of categorizing complications for their utility in assessing outcomes after randomized surgical trials. The CCI outperformed standard methods in...

JANS Article

Tumor Stage After Neoadjuvant Chemotherapy Determines Survival After Surgery for Adenocarcinoma of the Esophagus and Esophagogastric Junction

September 25, 2014 | Mark FergusonBronze Contributor

This retrospective review evaluated the relationship of pretreatment vs post-induction therapy stage to survival in patients undergoing surgery for esophageal adenocarcinoma in 2 centers in London. Among 584 pts, 400...

LOAD MORE
ADVERTISE ON CTSNET